A peer support community, independent and not for sale. Since February 2024.

GLP CircleA peer support community

Research reading group

SURMOUNT-1 and what the comparator actually was

Started 4 July 2025 · 19 replies · 180 hearts · read 3.5k times

XanBerlin, DE · 4 July 2025
about a year ago

SURMOUNT-1 and what the comparator actually was — putting it in its own thread so it does not get lost in the check-in.

I have read the paper and I am not sure I have understood it.

I have been trying to trace a claim back to its source and every trail ends at a summary of a summary, which is itself informative.

Evidence question. I would rather have an honest "we do not know" than a confident answer, and confident answers are all I have been able to find so far.

The figure is 1 and I would rather lead with it than bury it three paragraphs down and have somebody ask.

If anybody has the primary source, I would be very grateful for it — I have been going round in circles.

60

IzoldaVilnius, LT
#1

The paper we read last month had a population nothing like most of this circle, which does not make it useless and does limit what it tells us.

10me too 5

PádraigGalway, IE
#2

What surprised me was how readable most of these are once you stop being intimidated by the first page.

5

SunilFacilitatorBirmingham, UK
#3

I am pleased with this thread. Asking what the best single piece of human evidence is tends to end in an honest "very little", and a circle where nobody minds saying so is rarer than it ought to be.

22

PamSouthport, UK
#4

Sunil has already said most of this and I want to add the one part that was different for me.

I would say do read the supplementary material occasionally. Twice now the thing I wanted to know was only in there.

7

DoraUtrecht, NL
#5

The registry entry is worth checking against the published paper, and on one occasion the outcomes we were reading were not the ones originally listed.

10

AbelAddis Ababa, ET
#6

Well said, and thank you for taking the time over it.

7me too 9

TildaCambridge, UK
#7

Reading Abel, I recognised more of that than I expected to.

Something practical: I write three sentences about each paper afterwards and I now have two years of notes I actually refer back to.

6

AnnaAthens, GR
#8

My experience is that the group is much better at this than I am alone, because somebody always spots the thing I skimmed.

8

NissaHaifa, IL
#9

My reading has got slower and better. I get through a quarter of what I used to and I understand considerably more of it.

8

NilsUppsala, SE
#10

Tilda has already said most of this and I want to add the one part that was different for me.

Something worth knowing: the difference between a trial and an observational study changes what you can conclude, and I did not know that two years ago.

10

NadjaBelgrade, RS
#11

What I would say is that an honest "we do not know yet" is worth more than a confident answer, and the papers say it more often than the coverage does.

12

FabianBasel, CH
#12

The trial that gets quoted most in general coverage is not the one that answers most of the questions people here actually have.

5me too 4

JunoBrighton, UK
#13

Building on what Nils wrote rather than answering the original question.

Something practical: I read the methods before the conclusions now, which somebody here suggested and which changed how much I trust what I read.

9

PerrineStrasbourg, FR
#14

I had to learn that an effect being statistically significant and it mattering to a person are two entirely separate questions.

7

RuthieLeicester, UK
#15

Reading Perrine, I recognised more of that than I expected to.

The withdrawal numbers in a trial usually tell you more about tolerability than the tolerability section does.

11me too 8

SaoirseKilkenny, IE
#16

I found the funding declarations worth reading, not as an accusation, but because they tell you what question somebody was paying to have answered.

9

OrphBath, UK
#17

Something worth knowing: the follow-up periods in most of what we read are short relative to how long people actually take these things.

9

SunilFacilitatorBirmingham, UK
#18

Speaking as a facilitator: we do not post protocols in this circle. Describing what a study did is welcome; presenting a schedule as established is not.

14

BlueStroud, UK
#19

Nothing here is medical advice, and a paper is not a recommendation for any individual person including the ones in it.

11